| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized study of epirubicin monotherapy every four or every twoweeks in advanced breast cancer. A Hellenic Cooperative Oncology Groupstudy
|
G. Fountzilas
|
|
1997
|
8 |
12 |
p. 1213-1220
8 p.
|
artikel
|
| 2 |
Cardiac arrhythmias after cisplatin infusion: Three case reports and areview of the literature
|
D. Tassinari
|
|
1997
|
8 |
12 |
p. 1263-1267
5 p.
|
artikel
|
| 3 |
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapyand stem cell support: A retrospective multicenter study of the Austrian StudyGroup on Urologic Oncology
|
J. Pont
|
|
1997
|
8 |
12 |
p. 1229-1234
6 p.
|
artikel
|
| 4 |
Clinical oncology: Basic principles and practice. A. J. Neal, P. J. Hoskin (eds).
|
F. R. Hirsch
|
|
1997
|
8 |
12 |
p. 1284-1284
1 p.
|
artikel
|
| 5 |
Colony-stimulating factors. Molecular and cellular biology. J. M. Garland, P. J. Quesenberry, D. J. Hilton (eds).
|
A. M. Gianni
|
|
1997
|
8 |
12 |
p. 1176-1176
1 p.
|
artikel
|
| 6 |
Comparative antitumor efficacy of docetaxel and paclitaxel in nude micebearing human tumor xenografts that overexpress the multidrug resistanceprotein (MRP)
|
U. Vanhoefer
|
|
1997
|
8 |
12 |
p. 1221-1228
8 p.
|
artikel
|
| 7 |
Correlation between physical performance and fatigue in cancerpatients
|
F. Dimeo
|
|
1997
|
8 |
12 |
p. 1251-1255
5 p.
|
artikel
|
| 8 |
Differences in docetaxel and paclitaxel activity in resistant tumor cellswhich express MRP: Need of comparative clinical trials in resistantpatients
|
M. DIncalci
|
|
1997
|
8 |
12 |
p. 1183-1184
2 p.
|
artikel
|
| 9 |
Do authors of review articles use systematic methods to identify, assessand synthesize information?
|
V. H. C. Bramwell
|
|
1997
|
8 |
12 |
p. 1185-1195
11 p.
|
artikel
|
| 10 |
Ecco in Hamburg: A huge success; EU strives to prepare new directiveconcerning tobacco advertising; Middle East cancer consortium: NCI starts topay; BIG begins to work; EU: Bill, why are you so cautious?; Perhaps noteveryone knows that
|
|
|
1997
|
8 |
12 |
p. 1171-1175
5 p.
|
artikel
|
| 11 |
Epidermal growth factor receptor (EGFR) and EGFR mutations, function andpossible role in clinical trials
|
B. Rude Voldborg
|
|
1997
|
8 |
12 |
p. 1197-1206
10 p.
|
artikel
|
| 12 |
Experience with intraperitoneal cisplatin and etoposide and i.v. sodiumthiosulphate protection in ovarian cancer patients with either pathologicallycomplete response or minimal residual disease
|
R. E. N. van Rijswijk
|
|
1997
|
8 |
12 |
p. 1235-1241
7 p.
|
artikel
|
| 13 |
How much chemotherapy in advanced Hodgkins disease?
|
M. Björkholm
|
|
1997
|
8 |
12 |
p. 1281-1283
3 p.
|
artikel
|
| 14 |
Phase II study of the combination of the novel bioreductive agent,tirapazamine, with cisplatin in patients with advanced non-small-cell lungcancer
|
V. A. Miller
|
|
1997
|
8 |
12 |
p. 1269-1271
3 p.
|
artikel
|
| 15 |
Quality of life assessment and clinical decision-making
|
P. Casali
|
|
1997
|
8 |
12 |
p. 1207-1211
5 p.
|
artikel
|
| 16 |
Relationships between biochemical and symptomatic response in adouble-blind randomised trial of pamidronate for metastatic bone disease
|
J. J. F. Vinholes
|
|
1997
|
8 |
12 |
p. 1243-1250
8 p.
|
artikel
|
| 17 |
Single-agent high-dose melphalan salvage therapy for Hodgkins disease:Cost, safety, and long-term efficacy
|
D. A. Stewart
|
|
1997
|
8 |
12 |
p. 1277-1279
3 p.
|
artikel
|
| 18 |
Suppression of invasive behavior of melanoma cells by stable expressionof anti-sense perlecan cDNA
|
R. Adatia
|
|
1997
|
8 |
12 |
p. 1257-1261
5 p.
|
artikel
|
| 19 |
The bigger the better? ... or what we know and what we still need tolearn about anthracycline dose per course, dose density and cumulative dosein the treatment of breast cancer
|
L. Biganzoli
|
|
1997
|
8 |
12 |
p. 1177-1182
6 p.
|
artikel
|
| 20 |
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosedacute promyelocytic leukemia patients aged <60 years
|
R. Latagliata
|
|
1997
|
8 |
12 |
p. 1273-1275
3 p.
|
artikel
|
| 21 |
Undergraduate education in Oncology in the Balkans and Middle East
|
N. Pavlidis
|
|
1997
|
8 |
12 |
p. 1281-1281
1 p.
|
artikel
|
Tijdschrift beschrijving